Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARD | Q03181 | 2/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | DAO | P14920 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22973763 | 0.90 | PPARD (0.43) | PPARDTSHRMAPTPOLB | |
| SCHEMBL23005854 | 0.89 | PPARD (0.34) | PPARD | |
| SCHEMBL21428989 | 0.86 | PPARD (0.35) | PPARDTSHR | |
| SCHEMBL31418408 | 0.86 | PPARD (0.35) | PPARDTSHR | |
| SCHEMBL29108971 | 0.85 | PPARD (0.36) | PPARDTSHRMAPTPOLB | |
| SCHEMBL21408255 | 0.84 | CYP4A11 (0.36) | PPARDTSHRMAPTPOLB | |
| SCHEMBL22952372 | 0.82 | PPARD (0.35) | PPARDDAOMAPT | |
| SCHEMBL21428990 | 0.82 | PPARD (0.35) | PPARD | |
| SCHEMBL22973754 | 0.77 | PPARD (0.39) | PPARDTSHRMAPTPOLB | |
| SCHEMBL23006003 | 0.75 | PPARD (0.46) | PPARDTSHRMAPTPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3778612-B1 | PHOSPHATE DERIVATIVES AND USE THEREOF | SHANGHAI SHENGYUE PHARMACEUTICAL TECH CO LTD (CN) | 2025-02-12 | — | — | EP | disclosed |
| US-20210030773-A1 | PHOSPHATE DERIVATIVES AND USE THEREOF | Shanghai Shengyue Pharmaceutical Technology Co., Ltd. (CN) | 2021-02-04 | — | — | US | disclosed |
| WO-2019184866-A1 | PHOSPHATE DERIVATIVES AND USE THEREOF | 朱青 | 2019-10-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210030773-A1 | PHOSPHATE DERIVATIVES AND USE THEREOF | CXCL12, MIF, FGF23 | PPARD 2140/4885TSHR 4056/4885DAO 785/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.